Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

<h3>Background</h3><p dir="ltr">Some studies have reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity and mortality. This study aim...

Full description

Saved in:

Bibliographic Details
Main Author:	Elias Tayar (16488567) (author)
Other Authors:	Sami Abdeen (14779537) (author), Muna Abed Alah (14779534) (author), Hiam Chemaitelly (439114) (author), Iheb Bougmiza (8962583) (author), Houssein H. Ayoub (9262512) (author), Anvar Hassan Kaleeckal (11847034) (author), Ali Nizar Latif (11570540) (author), Riyazuddin Mohammad Shaik (11847037) (author), Hamad Eid Al-Romaihi (6837251) (author), Mohamed H. Al-Thani (11847049) (author), Roberto Bertollini (9538620) (author), Laith J. Abu-Raddad (9262524) (author), Abdullatif Al-Khal (11721410) (author)
Published:	2023
Subjects:	Biomedical and clinical sciences Cardiovascular medicine and haematology Clinical sciences Health sciences Public health Influenza COVID-19 Vaccine Case-control Immunity Epidemiology
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
by: Elias, Tayar
Published: (2023)

Seasonal influenza disease and annual influenza vaccine coverage at Primary Health Care Corporation, Qatar, 2018–2019: a descriptive study
by: Seema Sylvia Dsouza (21347870)
Published: (2022)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
by: Salman M. Toor (8854751)
Published: (2020)

Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict
by: Wesam S. Ahmed (10170053)
Published: (2023)

Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country
by: Wesam S. Ahmed (10170053)
Published: (2024)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
by: Swapna Thomas (17337925)
Published: (2023)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
by: Swapna, Thomas
Published: (2023)

Motivators and barriers of seasonal influenza vaccination among primary health care physicians in Qatar
by: Kamran Aziz (21633128)
Published: (2024)

BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
by: Hiam Chemaitelly (439114)
Published: (2024)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas (17337925)
Published: (2024)

SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
by: Mai A. Mahmoud (9620657)
Published: (2023)

Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
by: Watheq Thabet Taher (17541210)
Published: (2023)

Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
by: Swapna Thomas (17337925)
Published: (2022)

Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2
by: Hibah Shaath (5599658)
Published: (2020)

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
by: Queenie Fernandes (14557388)
Published: (2022)

Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey
by: Rajeev Kumar (195329)
Published: (2021)

T‐cell responses and therapies against SARS‐CoV‐2 infection
by: Salman M. Toor (8854751)
Published: (2023)

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
by: Hiam Chemaitelly (439114)
Published: (2024)

Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination
by: Salma Younes (6424865)
Published: (2024)

Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
by: Muhammad, Suleman
Published: (2024)

Mapping routine measles vaccination in low- and middle-income countries
by: Local Burden of Disease Vaccine Coverage Collaborators (11548903)
Published: (2020)

Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
by: Hussam Al Soub (17269024)
Published: (2021)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
by: Maria K. Smatti (4675852)
Published: (2022)

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
by: Heba N. Altarawneh (19482436)
Published: (2023)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
by: Suelen H. Qassim (13777594)
Published: (2023)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
by: Adeel A. Butt (3697705)
Published: (2023)

Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
by: Hebah A., Al-Khatib
Published: (2022)

Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1
by: Natalie C Galles (9715361)
Published: (2021)

SARS‐CoV‐2 infection triggers more potent antibody‐dependent cellular cytotoxicity (ADCC) responses than mRNA‐, vector‐, and inactivated virus‐based COVID‐19 vaccines
by: Hadeel T. Zedan (12535521)
Published: (2024)

Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
by: Hiam Chemaitelly (439114)
Published: (2023)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
by: Suelen H., Qassim
Published: (2023)

Malaria vaccination in Africa: A mini-review of challenges and opportunities
by: David B. Olawade (19325911)
Published: (2024)

Long COVID treated successfully with antivirals in a rituximab-treated follicular lymphoma patient with persistent negative-antibodies to SARS-CoV2
by: Elias Tayar (16488567)
Published: (2023)

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
by: Haissam Abou-Saleh (497840)
Published: (2022)

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024
by: Lambach, Philipp
Published: (2025)

Will influenza A(H3N8) cause a major public health threat?
by: Hadi M., Yassine
Published: (2022)

<i>In silico </i>formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever
by: Rahat Alam (9286527)
Published: (2023)

Hyponatremia and SARS-CoV-2 infection: A narrative review
by: Elmukhtar Habas (14777677)
Published: (2022)

Development and validation of a multi-dimensional COVID-19 vaccine hesitancy questionnaire
by: Hamed Hammoud (9639309)
Published: (2023)

Qatar COVID-19 vaccination story: what are the success drivers?
by: Khalid Elmardi (17868190)
Published: (2024)